Skip to main content
Advertisement

Japan’s Kobayashi Pharmaceutical reports new deaths potentially linked to red yeast rice supplements

01:40 Min

Japanese drugmaker Kobayashi Pharmaceutical has reported additional deaths potentially linked to its beni koji or red yeast rice supplements. It said on Aug 13 that it had failed to report nearly a dozen cases to the Health, Labour and Welfare Ministry previously. CNA's Michiyo Ishida has more.

Japanese drugmaker Kobayashi Pharmaceutical has reported additional deaths potentially linked to its beni koji or red yeast rice supplements. It said on Aug 13 that it had failed to report nearly a dozen cases to the Health, Labour and Welfare Ministry previously. CNA's Michiyo Ishida has more.

Advertisement

You May Also Like

Advertisement